Browsing by Title
Now showing items 6735-6754 of 19733
-
EP05.02-002 Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?
Tavara, B.; Garrido, M.L.; Rodríguez, Z.; Rojas, M.; López, L.; Medina, S.; Ponte, C.; Lopez, A.; Sanchez, E.; Pedraza, M.; Viñals, P.; López, M.; Alonso, D.; Rodríguez, A.; Davila, E.; Castañon, C.; De Sande, L.M.; Nieto, B.; Vallejo Pascual, María Eva
; Rodríguez, J.d.I.R.; Garcia Palomo, A.; Diz Taín, P. (2022)
-
EP05.02-003 Durvalumab after Chemoradiotherapy (CRT) in Unresectable Stage III NSCLC. Comparative Study of Two Cohorts in the Real-World Setting
Tavara, B.; Rojas, M.; Rodríguez, Z.; Garrido, M.L.; López, L.; Medina, S.; Ponte, C.; López, A.; Sanchez, E.; Pedraza, M.; Viñals, P.; Lopez, M.; Alonso, D.; Rodríguez, A.; Castañon, C.; Davila, E.; De Sande, L.M.; Nieto, B.; Vallejo Pascual, María Eva; Rodriguez, J.d.l.R.; Garcia Palomo, A.; Diz Taín, P. (2022)
-
La epigenética como nueva diana terapéutica
(2023-06-22) -
Epigenética en la era postgenoma
(2012-12)